We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
According to the FDA Report, Russia placed in the top 10 and ranked 2nd after the U.S. in terms of the number of subjects recruited. Russia is the world's 9th country by population (146 mln people), making it a patient pool more than sufficient for a study in almost any indication.
Today 145,000 patients are involved in 3,400 clinical trials in progress in Spain. While one out of three trials carried out in Europe already has Spanish participation, the country accounts for a 4.3% share of the global clinical trials activity with oncology as the leading therapeutic area.
In 2014-2019 Bulgaria was placed in the top 10 and ranked 8th in terms of the number of subjects recruited for studies according to the recent US FDA Report. 13 out of 50 novel drugs approved by the FDA in 2021 underwent studies in Bulgaria.
Poland is 10th place in the world by number of research sites (over 1,400). With a population of 38.5 mln people, it boasts successful recruitment rates, reasonable grants, and lower costs per patient than in the U.S., though higher than in Ukraine, Russia or Georgia.
Being an EU member since 2004, Latvia boasts a harmonized regulatory and legislative environment for international clinical trials. The majority of studies fall within the therapeutic areas of oncology, neurology, psychiatry, and endocrinology.
Belarus is a promising new player. Clinical research professionals are very particular about adhering to GCP standards. Local rules and standards are very close to those mandated by FDA and EMA.
Recruitment shows a significant number of eligible patients, including treatment-naïve ones. According to the MoH of Ukraine, leading therapeutic areas in 2020 are Oncology, Psychiatry, Neurology, Gastroenterology, and Hematology. The RA process takes up to 60 calendar days.
Turkey is gaining recognition as a notable clinical research hub. The 2020 EFPIA report placed the country at 26th worldwide for its volume of clinical trials. Turkey played a key role in the development of 4 out of 37 drugs that received FDA approval in 2022.

Delivering high-quality CRO services
since 2005

Experience the benefits of running your next study in Eastern Europe

Contact our regional office
Operations in 21 countries:

Germany (HQ)
Czech Republic
the Netherlands

More Countries
An official member of the European CRO Federation
up to
faster enrollment
access to
leading research sites
we have enrolled
patients up to date
we deliver
acceptable data

What our clients say about us

Full Range of Clinical Trial Services

We provide a full range of high-quality clinical trial services for Phase I-IV and BE studies. We offer both full-service clinical study engagements and standalone services.

We have worked with OCT on two separate occasions and have always been impressed by their professionalism and expertise.

James Barder
CEO, Futura Medical

The study has been going on during challenging times, and I am proud of our joint recruitment efforts with OCT Clinical. Without their resilience, energy, amazing control, efficiency and cooperative approach we wouldn’t have got here so soon.

Andreas Gerward
CEO, Stayble Therapeutics

We are happy that we came across OCT Clinical to run the next phase of our clinical study. We have been impressed with the CRO’s portfolio and are counting on their professionalism and performance.

Yong Liu
CEO, Recbio

300+ Studies in 29 Therapeutic Areas
Since 2005

All Therapeutic Areas

OCT Clinical to the Rescue

Rescue Studies as a Special Expertise

When clinical trials hit roadblocks, we are ready to step in. Each time we takeover an active trial, our experts create a study rescue plan focused on resolving current bottlenecks and study challenges and an expedited study schedule to get it back on track.

Request a Proposal

Our Clients

Other partners

Resource Library

OCT Clinical on the Road

Let′s Start a New Study Together

Thank you for your request!
Our team will respond to you within 24 hours.